THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01640639

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01640639
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01640639. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure
Acronym
THUNDER
Condition
Congestive Heart Failure
Intervention (Drug)
Thalidomide
Intervention (Drug)
Placebo
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01640639
Content hash
6ad76e62b505ff3c7662195cc62d7bcbee673a885b1a9b2907487b38a03de605